| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/21/2009 | US20090131360 Tripartite RNAi constructs |
| 05/21/2009 | US20090131346 Antibody and method for identification of dendritic cells |
| 05/21/2009 | US20090131327 Nogo receptor functional motifs and peptide mimetics related thereto and methods of using the same |
| 05/21/2009 | US20090131319 Protein of given amino acid sequence; heterologous polypeptide comprises Fc portion of antibody molecule; identifying agonists and antagonists; diagnosis and treatment of disease resulting from aberrant cell proliferation |
| 05/21/2009 | US20090131312 Non-natural chemokine receptor ligands and methods of use thereof |
| 05/21/2009 | US20090131277 Prostate cancer diagnosis and treatment |
| 05/21/2009 | US20090130776 Binding protein molecule |
| 05/21/2009 | US20090130716 Rationally designed antibodies |
| 05/21/2009 | US20090130715 Antibodies to CD40 |
| 05/21/2009 | US20090130695 Isolated nucleic acid encoding GEF-H1b polypeptide (Guanine nucleotide exchange factors); diagnosing abnormal cell proliferation and drug screening; measuring phosphorylation by p-21 activated kinase; antitumor agents, anticancer agents |
| 05/21/2009 | US20090130691 Screening proteinase modulators using a chimeric protein and ski-i proprotein convertase substrates and inhibitors |
| 05/21/2009 | US20090130662 Method for Diagnosis of Prostate Cancer |
| 05/21/2009 | US20090130132 Anti-caveolin-1 polyclonal antibody, and antigen peptide sequence and method for preparing the same |
| 05/21/2009 | US20090130130 Mutant allergen(s) |
| 05/21/2009 | US20090130129 Melanoma-associated endogenous retrovirus (MERV) derived peptide sequences and their therapeutic/diagnostic use |
| 05/21/2009 | US20090130125 Combination of tumor-associated surface protein antigens and tumor-associated sugars in the treatment and diagnosis of cancer |
| 05/21/2009 | US20090130124 Method for altering hematopoietic progenitor cell adhesion, differentiation, and migration |
| 05/21/2009 | US20090130123 Antibodies to west nile virus polypeptides |
| 05/21/2009 | US20090130120 monoclonal antibodies and fragments that bind to conserved epitopes of the G protein of respiratory syncytial virus(RSV) and which are minimally immunogenic when administered to humans, useful in treating RSV infections |
| 05/21/2009 | US20090130115 Antibodies recognizing a highly expressed putative antigen of ca-mrsa and methods of use |
| 05/21/2009 | US20090130114 Wise binding agents and epitopes |
| 05/21/2009 | US20090130113 Compositions and methods for use for antibodies against sclerostin |
| 05/21/2009 | US20090130111 Method of Identifying Membrane Ig Specific Antibodies and Use Thereof for Targeting Immunoglobulin-Producing Precursor Cells |
| 05/21/2009 | US20090130110 High affinity fully human monoclonal antibodies to interleukin-8 and epitopes for such antibodies |
| 05/21/2009 | US20090130107 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 05/21/2009 | US20090130106 Demibodies: dimerization-activated therapeutic agents |
| 05/21/2009 | US20090130105 Compositions that bind multiple epitopes of igf-1r |
| 05/21/2009 | US20090130104 Fusion proteins for inhibition and dissolution of coagulation |
| 05/21/2009 | US20090130103 Purification and protective efficacy of monodisperse and modified yersinia pestis capsular f1-v antigen fusion proteins for vaccination against plague |
| 05/21/2009 | US20090130102 Methods for humanizing antibodies and humanized antibodies made thereby |
| 05/21/2009 | US20090130099 Humanized antibodies and compositions for binding sphingosine-1-phosphate |
| 05/21/2009 | US20090130095 Composition comprising tumor necrosis factor (CD40) specific immunoglobulin for treatment and prevention of autoimmune diseases |
| 05/21/2009 | US20090130094 Cytotoxic Antibodies Directed Against Antibodies Inhibiting Factor VIII |
| 05/21/2009 | US20090130093 Binding member for gm-csf receptor |
| 05/21/2009 | US20090130089 Anti-cd20 antibodies and methods of use |
| 05/20/2009 | EP2060631A2 Characterization of granulocytic ehrlichia and methods of use |
| 05/20/2009 | EP2060630A2 PCA3, PCA3 genes, and methods of use |
| 05/20/2009 | EP2060628A1 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 05/20/2009 | EP2060270A2 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof |
| 05/20/2009 | EP2059594A1 Neukinase, a downstream protein of neuregulin |
| 05/20/2009 | EP2059593A2 Treating or preventing cancers over-expressing reg4 or kiaa0101 |
| 05/20/2009 | EP2059536A2 Optimized antibodies that target cd19 |
| 05/20/2009 | EP2059535A2 Prlr-specific antibody and uses thereof |
| 05/20/2009 | EP2059534A1 Engineered anti-il-23p19 antibodies |
| 05/20/2009 | EP2059533A2 Multispecific antibodies |
| 05/20/2009 | EP2059532A2 Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof |
| 05/20/2009 | EP2059531A1 Small streptococcus pyogenes antigens and their use |
| 05/20/2009 | EP2059258A2 Arginine wash in protein purification using affinity chromatography |
| 05/20/2009 | EP1835922B1 Combination treatment for multiple sclerosis |
| 05/20/2009 | EP1592789B1 Administration of transposon-based vectors to reproductive organs |
| 05/20/2009 | EP1578371A4 Compositions and methods for the diagnosis and treatment of tumor |
| 05/20/2009 | EP1574521B1 Method of protecting of thiol groups in antibodies |
| 05/20/2009 | EP1562620B1 Modified cytokines for use in cancer therapy |
| 05/20/2009 | EP1331944B1 Use of cd28-specific monoclonal antibodies for stimulating blood cells that lack cd28 |
| 05/20/2009 | CN101438167A Methods for diagnosing pancreatic cancer using REG4 protein |
| 05/20/2009 | CN101438165A In vivo induced genes of mycobacterium tuberculosis |
| 05/20/2009 | CN101437956A Humanized anti-CD20 monoclonal antibody |
| 05/20/2009 | CN101437852A Anti-TAT226 antibodies and immunoconjugates |
| 05/20/2009 | CN101437851A Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and prostate cancer |
| 05/20/2009 | CN101437850A Anti-5T4 antibodies and uses thereof |
| 05/20/2009 | CN101437847A Antibody-targeted cytokines for therapy |
| 05/20/2009 | CN101437540A Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| 05/20/2009 | CN101437537A Cancer vaccine |
| 05/20/2009 | CN101437536A Anti-tumor cell antigen antibody therapeutics |
| 05/20/2009 | CN101434956A Heavy and light chain variable region gene of monoclonal antibody, encoding polypeptide thereof and use |
| 05/20/2009 | CN101434954A Chinese bee royal jelly main protein AccMRJP7 gene and encoding protein thereof |
| 05/20/2009 | CN101434655A Preparation of egg yolk antibody against citrinin |
| 05/20/2009 | CN101434654A Neutralizing antibody against HGF and neutralizing antibody binding to the same |
| 05/20/2009 | CN101434653A Preparation and detection kit for human ARMET protein monoclonal antibody |
| 05/20/2009 | CN101434652A Pyrethroid pesticide artificial antigen, antibody and preparation thereof |
| 05/20/2009 | CN101433715A Modified chimeric polypeptides with improved pharmacokinetic properties |
| 05/20/2009 | CN100488984C Reducing immunogenicity of fusion proteins |
| 05/20/2009 | CN100488983C Technology for preparing colorless malachite green complete antigen and monoclonal antibody |
| 05/20/2009 | CN100488982C Methods of preparing monoclonal antibodies binding with beta-amyloid proteins and bringing the protein configuration conversion |
| 05/20/2009 | CN100488563C Modified anti-EGFR antibody with reduced immunogenicity |
| 05/19/2009 | US7534877 Non-M, non-O HIV-1 strains, fragments and uses |
| 05/19/2009 | US7534869 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 05/19/2009 | US7534868 Human antibodies to human delta like ligand 4 |
| 05/19/2009 | US7534866 Methods and compositions for generating bioactive assemblies of increased complexity and uses |
| 05/19/2009 | US7534857 Methods and compositions for the treatment and prevention of staphylococcal infections |
| 05/19/2009 | US7534856 PRO19624 antibodies |
| 05/19/2009 | US7534772 Methods for enhancing antibody-induced cell lysis and treating cancer |
| 05/19/2009 | US7534605 CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases |
| 05/19/2009 | US7534604 Fusion polypeptides capable of activating receptors |
| 05/19/2009 | US7534580 Invention identifies carrier protein to which PSP94 is bound (named PSP94-binding protein), its nucleic acid and amino acid sequences; use in diagnosis and prognosis of PSP94 related disease |
| 05/19/2009 | US7534577 Functional assays that use the T1R2 taste receptor to identify potential taste modulators |
| 05/19/2009 | US7534575 Method for detecting cancer using an antibody to Zcytor16 |
| 05/19/2009 | US7534572 Methods for treating neoplastic disease characterized by vascular endothelial growth factor D expression, for screening for neoplastic disease or metastatic risk, and for maintaining vascularization of tissue |
| 05/19/2009 | US7534564 Methods and compositions for polypeptide engineering |
| 05/19/2009 | US7534445 isolated nucleotide sequences and degenerate sequences encoding the high molecular weight HMW protein; vaccines; antibodies; vectors |
| 05/19/2009 | US7534444 Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies |
| 05/19/2009 | US7534440 Fusion molecules and methods for treatment of immune diseases |
| 05/19/2009 | US7534435 Glycosylated specificity exchangers |
| 05/19/2009 | US7534433 Feeding animal dietetic containing antibodies |
| 05/19/2009 | US7534432 Suppressing acitivity to treat musculodegenerative disease |
| 05/19/2009 | US7534431 Targetting antibodies containing haptens, cleaning agent, and drug delivery agent; tissue-directed therapy; solid phase synthesis |
| 05/19/2009 | US7534430 Administering monoclonal or polyclonal antibody to treat multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease |
| 05/19/2009 | US7534428 Antibodies to tumor necrosis factor receptors 6α and 6β |
| 05/19/2009 | US7534427 Predosing with non-radiolabeled antibody not performed |
| 05/19/2009 | US7534417 Nucleotide sequences coding 103P2D6-related protein for diagnosing various tumors; anticarcinogenic agents; genetic vaccines |